Metabolic characteristics of polycystic ovary syndrome patients with different body mass index and clinical phenotypes
Jiayi Liu,Shanmei Shen,Jing Wang,Bingjie Zhang,Fei Shao,Yandong Cheng,Ran Meng,Yali Jing,Wenhuan Feng,Qijun Fang,Yan Bi,Dalong Zhu
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2018.03.011
2018-01-01
Abstract:Objective To analyze the endocrine and metabolic characteristics of patients with polycystic ovary syndrome(PCOS)with different body mass indexes(BMI)and clinical phenotypes,so as to provide some new clues for the individualized and comprehensive clinical management of PCOS. Methods A total of 388 PCOS patients from December 2012 to December 2016 and 66 women with regular menstruation and normal androgen level matched with age and BMI were enrolled in this study.The PCOS patients were further divided into obese group and non-obese group according to their BMI,or were divided into four subgroups according to their clinical manifestations based on the 2003 Rotterdam criteria:oligo-and/or anovulation(O)+hyperandrogenism(H),O+polycystic ovary morphology(P),H+P and O+H+P. According to the status of hyperandrogenism, the PCOS patients were also divided into two subgroups:hyperandrogenism group (HA) and non-hyperandrogenism group (non-HA). The hormones and metabolic parameters were compared between different groups. Spearman correlation analysis was used for analyzed the association among sex hormones and glucose, lipid and uric acid metabolism and other related indicators.Results (1)There were significant differences in hormones and metabolic parameters between obese group and non-obese group(all P<0.05).The fasting insulin(FINS)in OH,HP and OHP group was significantly higher than that in control group[(20±13),(21±13),(22±15)vs(15±10)mU/L,all P<0.05].The serum FINS level in OHP group was significantly higher than that in OP group[(22±15)vs(17±12)mU/L, P<0.05]. Homeostasis model assessment-insulin resistance (HOMA-IR) in OHP group was significantly higher than that in control group (5.2 ± 3.9 vs 3.4 ± 2.4, P<0.05). (2) The serum level of high density lipoprotein-cholesterol(HDL-C)in OH group,HP group and OHP group was significantly lower than that in control group.The serum level of low density lipoprotein-cholesterol(LDL-C)in HP group was significantly higher than that in control group and OP group(all P<0.05).(3)The differences in BMI,FINS,postprandial insulin,HOMA-IR,HDL-C and sex hormone binding globulin(SHBG)between HA group and non-HA group [(28±6)vs(26±6)kg/m2,(22±14)vs(17±12)mU/L,(153±111)vs(121±88)mU/L,5±4 vs 4±3,(1.1±0.3)vs (1.2±0.3)mmol/L,(22±13)vs(41±23)nmol/L,t=-2.805-3.891]were significant(all P<0.05).(4)SHBG was negatively correlated with fasting plasma glucose, FINS, HOMA-IR, serum uric acid (SUA), triglyceride (TG), LDL-C (r=-0.233--0.147,all P<0.05), and was positively correlated with HDL-C (r=0.384, P<0.001).Free androgen index was positively correlated with FINS,HOMA-IR,SUA,TG(r=0.143-0.231,all P<0.05),and was negatively correlated with HDL-C(r=-0.160,P=0.012).Conclusion Hyperandrogenism and obesity may increase the risk of endocrine and metabolic disorders in PCOS patients. PCOS patients with different clinical phenotypes have different endocrine and metabolic characteristics.